James Cireddu, MD
- Medical Director, Harrington Heart and Vascular Institute, UH Regional Hospitals Bedford Campus
- Clinical Assistant Professor, CWRU School of Medicine
James Cireddu, MD, is an invasive cardiologist and medical director of University Hospitals Harrington Heart & Vascular Institute at University Hospitals Bedford Medical Center. He is a Cleveland-area native and appreciates the opportunity to care for his community.
Dr. Cireddu offers comprehensive care for heart disease prevention, hypertension, hyperlipidemia, valvular disease, arrhythmia or abnormal heart rhythms, coronary artery disease, heart attacks, heart failure or cardiomyopathy, peripheral vascular disease and venous disease management.
Dr. Cireddu sees both inpatients (hospitalized) and outpatients (office visits) throughout the UH system, including UH Bedford, UH Richmond, UH Ahuja (Beachwood) and UH Cleveland medical centers.
Dr. Cireddu's services include echocardiography, transesophageal echocardiography, nuclear/myocardial perfusion imaging, stress testing, coronary artery calcium scoring, CT angiography, cardiac catheterization, and comprehensive cardiology consultations.
Dr. Cireddu is welcoming new patients at his Bedford office.
- Cardiac Catheterization
- Cardiovascular Diseases
- Heart Disease
- Heart Failure
- Home Health Care
- Stress Testing
- Vascular Imaging (CTA, MRA)
- Vein Ablation
- Vein Disease
Patient Experience Reviews
4.7 out of 5
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Cardiovascular Medicine
Cardiovascular Medicine - Metrohealth Medical Center (2012 - 2015)
Residency | Internal Medicine
Internal Medicine - Uh Case Medical Center (2009 - 2012)
University Of Toledo College Of Medicine (2009)
Hiram College (2005)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, James Cireddu did not disclose any Outside Relationships with Industry.